Dieterich Douglas, Graham Camilla, Wang Su, Kwo Paul, Lim Young-Suk, Liu Chun-Jen, Agarwal Kosh, Sulkowski Mark
Division of Liver Disease, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
Division of Infectious Disease, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Gastro Hep Adv. 2022 Oct 14;2(2):209-218. doi: 10.1016/j.gastha.2022.10.004. eCollection 2023.
Hepatitis B virus (HBV) infection continues to threaten millions of lives across the globe, despite universal vaccination efforts. Current guidelines for screening, vaccination, and treatment are complex and have left too many people undiagnosed or improperly managed. Antiviral therapy has been shown to significantly reduce the incidence of liver-related complications, including liver cancer. However, the complexity of existing guidelines can make it difficult to identify which patients to target for treatment, and recommendations that are difficult to implement in real-world settings pose a barrier to eligible patients to receive therapy and contribute to health disparities in HBV care. The goal of this global expert panel was to gain consensus on a streamlined approach to HBV care to facilitate implementation of HBV intervention and treatment, especially in the primary care setting.
A group of 8 liver and infectious disease specialists attended a meeting in January 2021 with the objective of gaining consensus on a streamlined algorithm for HBV care that would encourage implementation of HBV intervention and treatment.
We have created a comprehensive perspective highlighting screening optimization, diagnostic workup, treatment, and monitoring. This treatment algorithm is designed to provide a streamlined visual pathway for risk stratification and management of patients with HBV that can be adapted in various care settings.
Simplification of guidelines will be critical to achieving health equity to address this public health threat and achieve HBV elimination.
尽管进行了普遍的疫苗接种工作,但乙型肝炎病毒(HBV)感染仍继续威胁着全球数百万人的生命。目前关于筛查、疫苗接种和治疗的指南很复杂,导致太多人未被诊断或管理不当。抗病毒治疗已被证明能显著降低包括肝癌在内的肝脏相关并发症的发生率。然而,现有指南的复杂性可能使确定哪些患者为治疗对象变得困难,而且在现实环境中难以实施的建议对符合条件的患者接受治疗构成了障碍,并导致了HBV治疗中的健康差距。这个全球专家小组的目标是就简化的HBV治疗方法达成共识,以促进HBV干预和治疗的实施,特别是在初级保健环境中。
一组8名肝脏和传染病专家于2021年1月参加了一次会议,目的是就简化的HBV治疗算法达成共识,该算法将鼓励实施HBV干预和治疗。
我们创建了一个全面的视角,突出了筛查优化、诊断检查、治疗和监测。这个治疗算法旨在为HBV患者的风险分层和管理提供一条简化的可视化途径,可在各种护理环境中进行调整。
简化指南对于实现健康公平以应对这一公共卫生威胁并实现消除HBV至关重要。